GHRL and obesity due to melanocortin 4 receptor deficiency: Many studies have demonstrated that people with schizophrenia who take second-generation antipsychotic drugs like olanzapine and risperidone frequently develop symptoms like diabetes and obesity, which may be because that the second-generation antipsychotics might increase the production of ghrelin [103].